Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthcare Triangle (HCTI) Receivables (2020 - 2025)

Healthcare Triangle's Receivables history spans 6 years, with the latest figure at $5.9 million for Q3 2025.

  • For Q3 2025, Receivables rose 151.29% year-over-year to $5.9 million; the TTM value through Sep 2025 reached $5.9 million, up 151.29%, while the annual FY2024 figure was $1.2 million, 65.42% down from the prior year.
  • Receivables for Q3 2025 was $5.9 million at Healthcare Triangle, up from $5.2 million in the prior quarter.
  • Across five years, Receivables topped out at $10.5 million in Q4 2021 and bottomed at $143000.0 in Q1 2025.
  • The 5-year median for Receivables is $5.2 million (2023), against an average of $4.9 million.
  • The largest YoY upside for Receivables was 151.29% in 2025 against a maximum downside of 93.28% in 2025.
  • A 5-year view of Receivables shows it stood at $10.5 million in 2021, then tumbled by 33.83% to $6.9 million in 2022, then crashed by 48.0% to $3.6 million in 2023, then tumbled by 55.47% to $1.6 million in 2024, then surged by 269.82% to $5.9 million in 2025.
  • Per Business Quant, the three most recent readings for HCTI's Receivables are $5.9 million (Q3 2025), $5.2 million (Q2 2025), and $143000.0 (Q1 2025).